Literature DB >> 11907512

Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea.

Jonathan Wilkin1, Mark Dahl, Michael Detmar, Lynn Drake, Alvan Feinstein, Richard Odom, Frank Powell.   

Abstract

Mesh：

Year:  2002        PMID： 11907512     DOI： 10.1067/mjd.2002.120625

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  119 in total

1.  Neurovascular and neuroimmune aspects in the pathophysiology of rosacea.

Authors:  Verena D Schwab; Mathias Sulk; Stephan Seeliger; Pawel Nowak; Jerome Aubert; Christian Mess; Michel Rivier; Isabelle Carlavan; Patricia Rossio; Dieter Metze; Jörg Buddenkotte; Ferda Cevikbas; Johannes J Voegel; Martin Steinhoff
Journal:  J Investig Dermatol Symp Proc       Date:  2011-12

Review 2.  Rosacea: The cytokine and chemokine network.

Authors:  Peter Arne Gerber; Bettina Alexandra Buhren; Martin Steinhoff; Bernhard Homey
Journal:  J Investig Dermatol Symp Proc       Date:  2011-12

3.  Use of oral isotretinoin in the management of rosacea.

Authors:  Hyunhee Park; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2011-09

Review 4.  Clinical, cellular, and molecular aspects in the pathophysiology of rosacea.

Authors:  Martin Steinhoff; Jörg Buddenkotte; Jerome Aubert; Mathias Sulk; Pawel Novak; Verena D Schwab; Christian Mess; Ferda Cevikbas; Michel Rivier; Isabelle Carlavan; Sophie Déret; Carine Rosignoli; Dieter Metze; Thomas A Luger; Johannes J Voegel
Journal:  J Investig Dermatol Symp Proc       Date:  2011-12

5.  Soolantra (Ivermectin) 1% Cream: A Novel, Antibiotic-Free Agent Approved for the Treatment of Patients with Rosacea.

Authors:  Lisa A Raedler
Journal:  Am Health Drug Benefits       Date:  2015-03

Review 6.  Rosacea: new and emerging treatments.

Authors:  Farah A Moustafa; Laura F Sandoval; Steven R Feldman
Journal:  Drugs       Date:  2014-09       Impact factor: 9.546

Review 7.  [Rosacea 2009 : new advances in pathophysiology, clinical staging and therapeutic strategies].

Authors:  A Sobottka; P Lehmann
Journal:  Hautarzt       Date:  2009-12       Impact factor: 0.751

8.  Molecular and Morphological Characterization of Inflammatory Infiltrate in Rosacea Reveals Activation of Th1/Th17 Pathways.

Authors:  Timo Buhl; Mathias Sulk; Pawel Nowak; Jörg Buddenkotte; Ian McDonald; Jérôme Aubert; Isabelle Carlavan; Sophie Déret; Pascale Reiniche; Michel Rivier; Johannes J Voegel; Martin Steinhoff
Journal:  J Invest Dermatol       Date:  2015-04-07       Impact factor: 8.551

9.  Quality of Life in Individuals with Erythematotelangiectatic and Papulopustular Rosacea: Findings From a Web-based Survey.

Authors:  Joshua A Zeichner; Lawrence F Eichenfield; Steven R Feldman; J Scott Kasteler; Ilia L Ferrusi
Journal:  J Clin Aesthet Dermatol       Date:  2018-02-01

Review 10.  Interventions for rosacea.

Authors:  Esther J van Zuuren; Zbys Fedorowicz; Ben Carter; Mireille M D van der Linden; Lyn Charland
Journal:  Cochrane Database Syst Rev       Date:  2015-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.